0

IN THIS ISSUE

JAMA: The Journal of the American Medical Association

June 21, 2006, Vol 295, No. 23
Basic View  |  Expanded View
At Face ValueAt Face Value
Topics:
JAMA. 2006;295(23):2701-2702.  doi: 10.1001/jama.295.23.2701
Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: Title and subTitle BreakThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial FREE
Victor G. Vogel, MD, MHS; Joseph P. Costantino, DrPH; D. Lawrence Wickerham, MD; Walter M. Cronin, MPH; Reena S. Cecchini, MS; James N. Atkins, MD; Therese B. Bevers, MD; Louis Fehrenbacher, MD; Eduardo R. Pajon, MD; James L. Wade, MD; André Robidoux, MD; Richard G. Margolese, MD, CM; Joan James, PA-C; Scott M. Lippman, MD; Carolyn D. Runowicz, MD; Patricia A. Ganz, MD; Steven E. Reis, MD; Worta McCaskill-Stevens, MD; Leslie G. Ford, MD; V. Craig Jordan, PhD, DSc; Norman Wolmark, MD; for the National Surgical Adjuvant Breast and Bowel Project (NSABP)
Topics: raloxifene, tamoxifen, breast cancer, national surgical adjuvant breast and bowel project, breast cancer, invasive, study of tamoxifen and raloxifene
JAMA. 2006;295(23):2727-2741.  doi: 10.1001/jama.295.23.joc60074
Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention: Title and subTitle BreakThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial FREE
Stephanie R. Land, PhD; D. Lawrence Wickerham, MD; Joseph P. Costantino, DrPH; Marcie W. Ritter, PhD; Victor G. Vogel, MD, MHS; Myoungkeun Lee, MS; Eduardo R. Pajon, MD; James L. Wade, MD; Shaker Dakhil, MD; James B. Lockhart, MD; Norman Wolmark, MD; Patricia A. Ganz, MD
Topics: raloxifene, tamoxifen, quality of life, breast cancer, national surgical adjuvant breast and bowel project, study of tamoxifen and raloxifene, leg cramp, health maintenance/preventive medicine
JAMA. 2006;295(23):2742-2751.  doi: 10.1001/jama.295.23.joc60075
Statin Use and Incident Nuclear Cataract FREE
Barbara E. K. Klein, MD, MPH; Ronald Klein, MD, MPH; Kristine E. Lee, MS; Lisa M. Grady, BS
Topics: statins, cataract, cataract, nuclear
JAMA. 2006;295(23):2752-2758.  doi: 10.1001/jama.295.23.2752
How Conducting a Clinical Trial Affects Physicians' Guideline Adherence and Drug Preferences FREE
Morten Andersen, MD, PhD; Jakob Kragstrup, MD, PhD, DMSc; Jens Søndergaard, MD, PhD
Topics: asthma, guideline adherence, inhaled corticosteroid, agonists, prescribing behavior
JAMA. 2006;295(23):2759-2764.  doi: 10.1001/jama.295.23.2759
Clinician's Corner
Prophylaxis Strategies for Contrast-Induced Nephropathy FREE
Neesh Pannu, MD; Natasha Wiebe, MMath, PStat; Marcello Tonelli, MD, SM; for the Alberta Kidney Disease Network
Includes: CME
Topics: radiographic contrast agent nephropathy
JAMA. 2006;295(23):2765-2779.  doi: 10.1001/jama.295.23.2765
Expected and Unanticipated Consequences of the Quality and Information Technology Revolutions
Robert M. Wachter, MD
Topics: information sciences, communication and information technology
JAMA. 2006;295(23):2780-2783.  doi: 10.1001/jama.295.23.2780
Selective Estrogen Receptor Modulators and Prevention of Invasive Breast Cancer
William J. Gradishar, MD; David Cella, PhD
Topics: selective estrogen receptor modulators, tamoxifen, breast cancer, breast cancer, invasive, health maintenance/preventive medicine
JAMA. 2006;295(23):2784-2786.  doi: 10.1001/jama.295.23.jed60037
Clinical Trial Investigators and Their Prescribing Patterns: Title and subTitle BreakAnother Dimension to the Relationship Between Physician Investigators and the Pharmaceutical Industry
Bruce M. Psaty, MD, PhD; Drummond Rennie, MD
Topics: drug industry, prescribing behavior
JAMA. 2006;295(23):2787-2790.  doi: 10.1001/jama.295.23.2787
Statins and the Risk of Cancer—ReplyStatins and the Risk of Cancer—Reply
Topics:
JAMA. 2006;295(23):2720-2722.  doi: 10.1001/jama.295.23.2721-b
Statins and the Risk of CancerStatins and the Risk of Cancer
Topics:
JAMA. 2006;295(23):2720-2722.  doi: 10.1001/jama.295.23.2721-a
Statins and the Risk of CancerStatins and the Risk of Cancer
Topics:
JAMA. 2006;295(23):2720-2722.  doi: 10.1001/jama.295.23.2720-b
Statins and the Risk of CancerStatins and the Risk of Cancer
Topics:
JAMA. 2006;295(23):2720-2722.  doi: 10.1001/jama.295.23.2720-a
Cost-effectiveness Analysis in the United StatesCost-effectiveness Analysis in the United States
Topics:
JAMA. 2006;295(23):2722-2723.  doi: 10.1001/jama.295.23.2722-a
Cost-effectiveness Analysis in the United States—ReplyCost-effectiveness Analysis in the United States—Reply
Topics:
JAMA. 2006;295(23):2722-2723.  doi: 10.1001/jama.295.23.2722-b
Cost-effectiveness and Resource AllocationCost-effectiveness and Resource Allocation
Topics:
JAMA. 2006;295(23):2723-2724.  doi: 10.1001/jama.295.23.2723-a
Cost-effectiveness and Resource Allocation—ReplyCost-effectiveness and Resource Allocation—Reply
Topics:
JAMA. 2006;295(23):2723-2724.  doi: 10.1001/jama.295.23.2723-b
Repair of Inguinal Hernia vs Watchful WaitingRepair of Inguinal Hernia vs Watchful Waiting
Topics:
JAMA. 2006;295(23):2724-2725.  doi: 10.1001/jama.295.23.2724-b
Repair of Inguinal Hernia vs Watchful WaitingRepair of Inguinal Hernia vs Watchful Waiting
Topics:
JAMA. 2006;295(23):2724-2725.  doi: 10.1001/jama.295.23.2724-a
Repair of Inguinal Hernia vs Watchful Waiting—ReplyRepair of Inguinal Hernia vs Watchful Waiting—Reply
Topics:
JAMA. 2006;295(23):2724-2725.  doi: 10.1001/jama.295.23.2725-a
Incomplete Financial Disclosure for Study of Funding and Outcomes in Major Cardiovascular TrialsIncomplete Financial Disclosure for Study of Funding and Outcomes in Major Cardiovascular Trials
Topics:
JAMA. 2006;295(23):2725-2726.  doi: 10.1001/jama.295.23.2725-b
Fat Cells and Insulin ResistanceFat Cells and Insulin Resistance
Topics: insulin resistance, adipocytes, insulin
JAMA. 2006;295(23):2711-2711.  doi: 10.1001/jama.295.23.2711-d
Older Drugs for Avian FluOlder Drugs for Avian Flu
Topics: aves, influenza a virus, avian
JAMA. 2006;295(23):2711-2711.  doi: 10.1001/jama.295.23.2711-c
Prostate Cancer GeneProstate Cancer Gene
Topics: cancer, genes, prostate cancer
JAMA. 2006;295(23):2711-2711.  doi: 10.1001/jama.295.23.2711-a
WHO Leader DiesWHO Leader Dies
Topics: world health organization
JAMA. 2006;295(23):2711-2711.  doi: 10.1001/jama.295.23.2711-b
Update: Multistate Outbreak of Mumps—United States, January 1-May 2, 2006Update: Multistate Outbreak of Mumps—United States, January 1-May 2, 2006 FREE
Topics: disease outbreaks, mumps
JAMA. 2006;295(23):2712-2717.  doi: 10.1001/jama.295.23.2712
Place of Death After Stroke—United States, 1999-2002Place of Death After Stroke—United States, 1999-2002 FREE
Topics: cerebrovascular accident, ischemic stroke
JAMA. 2006;295(23):2717-2718.  doi: 10.1001/jama.295.23.2717
The Grands BoulevardsThe Grands Boulevards
Topics:
JAMA. 2006;295(23):2698-2698.  doi: 10.1001/jama.295.23.2698
RevisionRevision
Topics:
JAMA. 2006;295(23):2700-2700.  doi: 10.1001/jama.295.23.2700
THE NEW HYGIENE.THE NEW HYGIENE.
Topics:
JAMA. 2006;295(23):2798-2798.  doi: 10.1001/jama.295.23.2798
About This Journal FREE
Topics:
JAMA. 2006;295(23):2694-2694.  doi: 10.1001/jama.295.23.2694
National Plan for Pandemic Flu UnveiledNational Plan for Pandemic Flu Unveiled
Topics: influenza, pandemic
JAMA. 2006;295(23):2707-2708.  doi: 10.1001/jama.295.23.2707
Group Backs Emergency ContraceptionGroup Backs Emergency Contraception
Topics: back, contraception, postcoital
JAMA. 2006;295(23):2708-2709.  doi: 10.1001/jama.295.23.2708
CDC: Immunize More Children for InfluenzaCDC: Immunize More Children for Influenza
Topics: influenza, centers for disease control and prevention (u.s.), immunization
JAMA. 2006;295(23):2709-2709.  doi: 10.1001/jama.295.23.2709
Scientists Plan New Orleans Mold ProjectScientists Plan New Orleans Mold Project
Topics: mold
JAMA. 2006;295(23):2710-2710.  doi: 10.1001/jama.295.23.2710
Topics:
JAMA. 2006;295(23):2791-2795.  doi: 10.1001/jama.295.23.2794
Leprosy, HistoryLeprosy, History
Topics:
JAMA. 2006;295(23):2791-2795.  doi: 10.1001/jama.295.23.2793
Mood DisordersMood Disorders
Topics:
JAMA. 2006;295(23):2791-2795.  doi: 10.1001/jama.295.23.2792
PharmacologyPharmacology
Topics:
JAMA. 2006;295(23):2791-2795.  doi: 10.1001/jama.295.23.2791
Effect of Blood Presssure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease: Results From the AASK Trial—Correction
Topics:
JAMA. 2006;295(23):2726-2726.  doi: 10.1001/jama.295.23.2726-c
Reported Outcomes in Major Cardiovascular Clinical Trials Funded by For-Profit and Not-for-Profit Organizations: 2000-2005—Correction
Topics:
JAMA. 2006;295(23):2726-2726.  doi: 10.1001/jama.295.23.2726-b
The Asymptomatic Hernia: ‘If It's Not Broken, Don't Fix It’—Correction
Topics:
JAMA. 2006;295(23):2726-2726.  doi: 10.1001/jama.295.23.2726
Watchful Waiting vs Repair of Inguinal Hernia in Minimally Symptomatic Men: A Randomized Clinical Trial—Correction
Topics:
JAMA. 2006;295(23):2726-2726.  doi: 10.1001/jama.295.23.2726-a
Randomized Controlled Trials FREE
Janet M. Torpy, MD; Cassio Lynm, MA; Richard M. Glass, MD
Topics: informed consent, cancer, centers for disease control and prevention (u.s.), united states national institutes of health, ethics, research, national cancer institute, medical research
JAMA. 2006;295(23):2812-2812.  doi: 10.1001/jama.295.23.2812

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

© 2012 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems